ClinicalTrials.Veeva

Menu

ALI in Cancer Patients

A

Assiut University

Status

Not yet enrolling

Conditions

Acute Limb Ischemia

Study type

Observational

Funder types

Other

Identifiers

NCT06882187
ALI in Cancer Patients .

Details and patient eligibility

About

The aim of the study is to describe and evaluate the outcomes of cancer patients presenting with and treated for ALI at our center .

Full description

Acute limb ischemia (ALI) is a vascular emergency and is associated with significant morbidity and mortality. Peripheral arterial embolism or thrombosis from malignant disease is uncommon and a rare cause of acute limb ischemia. Limb ischemia can be caused by emboli from the tumor itself, from metastatic deposits within large vessels, as well as the tumors of adjacent organs such as the lung, which invade the left or right atrium of the heart and then disseminate to the main arteries of the body. This acute event may be the first indication of malignant disease in the patient.

Enrollment

40 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • All cancer patient presented to Vascular and Endovascular surgery departement with ALI.

Exclusion criteria

  • Patients with benign tumors or without active malignancy.
  • Patients with iatrogenic limb ischemia related to a tumor chemoembolization procedure.

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems